The Effect of Patient Factors and Cotreatments on the Magnitude of Potassium Lowering with Insulin–Glucose Treatment in Patients with Hyperkalemia

The management of hyperkalemia with insulin–glucose/dextrose treatment (IDT) may be influenced by patient factors and cotreatments. We aimed to determine the magnitude of potassium lowering by IDT while considering patient factors and cotreatments. We observed the change in serum potassium in 410 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Andy K. H., Crnobrnja, Ljiljana, Metlapalli, Manogna, Govinna, Mauli, Jiang, Cathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620900/
https://www.ncbi.nlm.nih.gov/pubmed/36417187
http://dx.doi.org/10.3390/epidemiologia2010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620900/
https://www.ncbi.nlm.nih.gov/pubmed/36417187
http://dx.doi.org/10.3390/epidemiologia2010003

Ejemplares similares